Patent Assignment
Reel/Frame 017468/0289
Change of Name
Recorded: 2006-03-29
Pages: 11
Assignor
BIOGEN, INC.
Executed: 2003-11-13
Assignee
BIOGEN IDEC MA INC.
14 CAMBRIDGE CENTER, CAMBRIDGE, MASSACHUSETTS, 02142
Covered Properties
(21)
Dna Sequences, Recombinant Dna Molecules and Processes for Producing Lymphocyte Function Associated Antigen-3
Patent:
4,956,281 →
Application:
07/057,615 →
CD2-Binding Domain of Lymphocyte Function Associated Antigen 3 (Lfa-3)
Application:
07/667,971 →
CD2-Binding Domain of Lymphocyte Function Associated Antigen 3 (Lfa-3)
Application:
07/770,967 →
Method of Prophylaxis or Treatment of Antigen Presenting Cell Driven Skin Conditions Using Inhibitors of the CD2/Lfa-3 Interaction
Application:
07/770,969 →
Method of Prophylaxis or Treatment of Antigen Presenting Cell Driven Skin Conditions Using Inhibitors of the CD2/Lfa-3 Interaction
Application:
07/862,022 →
CD2-Binding Domain of Lymphocyte Function Associated Antigen 3
Patent:
5,547,853 →
Application:
07/940,861 →
Methods of Inhibiting T-Cell Dependent Proliferation of Peripheral Blood Lymphocytes Using the CD2-Binding Domain of Lymphocyte Function Assoiciated Antigen 3
Patent:
5,728,677 →
Application:
08/459,512 →
CD2-Binding Domain of Lymphocyte Function Associated Antigen 3
Patent:
5,914,111 →
Application:
08/459,657 →
Method of Using CD2 Binding Domain of Lymphocyte Function Associated Antigen 3 to Initiate T Cell Activation.
Patent:
5,928,643 →
Application:
08/460,132 →
Method of Prophylaxis or Treatment of Antigen Presenting Cell Driven Skin Conditions Using Inhibitors of the CD2/Lfa-3 Interaction
Patent:
6,162,432 →
Application:
08/466,465 →
Method of Prophylaxis or Treatment of Antigen Presenting Cell Driven Skin Conditions Using Inhibitors of the CD2/Lfa-3 Interaction
Method of modulating memory effector T-cells and compositions
Application:
09/796,033 →
Publication:
US 2002/0009446
Methods for treating or preventing skin disorders using CD2-binding agents
Application:
10/329,599 →
Publication:
US 2003/0185824
Method for Treating or Preventing Sclerotic Disorders Using Cd-2 Binding Agents
Methods of Treating Skin Conditions Using Inhibitors of the CD2/Lfa-3 Interaction
Methods of treating skin conditions using inhibitors of the CD2/LFA-3 interaction
Application:
11/282,853 →
Publication:
US 2006/0084107
Methods for treating or preventing skin disorders using CD2-binding agents
Application:
11/312,627 →
Publication:
US 2007/0031443
Method of Modulating Memory Effector T-Cells and Compositions
Application:
60/098,456 →
Methods for treating or preventing skin conditions using CD2-binding agents
Application:
60/265,964 →
Methods for treating or preventing sclerotic disorders using CD2-binding agents
Application:
60/307,688 →
Methods for treating or preventing sclerotic disorders using CD2-binding agents
Application:
60/382,459 →
Related Assignments
(5)
Other recorded transfers of the patents in this record — the chain of ownership.
Change of Name
Apr 15, 2004
From: BIOGEN IDEC MA, INC.
To: BIOGEN IDEC MA INC.
Reel/Frame 014520/0982 →
Change of Name
Apr 15, 2004
From: BIOGEN, INC.
To: BIOGEN IDEC MA, INC.
Reel/Frame 014532/0091 →
Assignment of Assignor's Interest
Mar 24, 2006
From: VAISHNAW, AKSHAY K.
To: BIOGEN, INC.
Reel/Frame 017377/0709 →
Assignment of Assignor's Interest
May 9, 2006
From: BIOGEN IDEC MA INC.
To: ASTELLAS US LLC
Reel/Frame 017596/0467 →
Assignment of Assignor's Interest
Feb 16, 2007
From: MAGILAVY, DANIEL
To: ASTELLAS US LLC
Reel/Frame 018900/0253 →